bpc 157 clinical trials 2025 Discover BPC-157: its first randomized, placebo-controlled human trial is now recruiting. Thirty years of preclinical data and exactly one prior human study defined the evidence base until now. A systematic review dihexa clinical trials humans BPC

My skin looked and felt so much better afterwards

Some patients have experienced the following: Patients were more susceptible to side effects when mixing the treatment with other injections or medications

This "paradoxical response" (where treatment temporarily makes symptoms worse) includes: Numbness and tingling Shooting pains Joint pain Increased sensitivity Temporary inflammation (swelling and irritation) While these symptoms generally indicate that treatment is working (as nerves begin to repair themselves), they can be distressing for patients and may require additional treatment for comfort

You feel the resistance and can adjust accordingly

A.VollsetS

Walter Kolch, [email protected] These authors share senior authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers